Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 33% ± 10% | |
lung | 11 studies | 30% ± 11% | |
brain | 10 studies | 30% ± 10% | |
intestine | 7 studies | 27% ± 11% | |
eye | 7 studies | 28% ± 9% | |
kidney | 6 studies | 28% ± 9% | |
bone marrow | 5 studies | 31% ± 12% | |
liver | 5 studies | 32% ± 19% | |
lymph node | 5 studies | 29% ± 6% | |
pancreas | 3 studies | 30% ± 8% | |
placenta | 3 studies | 31% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5553.34 | 2642 / 2642 | 100% | 64.92 | 705 / 705 |
esophagus | 100% | 3510.95 | 1445 / 1445 | 100% | 29.97 | 183 / 183 |
kidney | 100% | 5011.67 | 89 / 89 | 100% | 49.27 | 901 / 901 |
lung | 100% | 5543.76 | 578 / 578 | 100% | 54.86 | 1155 / 1155 |
ovary | 100% | 3904.73 | 180 / 180 | 100% | 52.07 | 430 / 430 |
prostate | 100% | 4749.09 | 245 / 245 | 100% | 76.67 | 502 / 502 |
stomach | 100% | 3959.47 | 359 / 359 | 100% | 45.69 | 286 / 286 |
thymus | 100% | 4157.92 | 653 / 653 | 100% | 67.64 | 604 / 605 |
intestine | 100% | 4851.88 | 966 / 966 | 100% | 56.43 | 526 / 527 |
bladder | 100% | 4237.76 | 21 / 21 | 100% | 61.92 | 503 / 504 |
uterus | 100% | 4358.34 | 170 / 170 | 100% | 73.78 | 458 / 459 |
skin | 100% | 4057.18 | 1808 / 1809 | 100% | 71.76 | 471 / 472 |
breast | 100% | 4946.34 | 459 / 459 | 100% | 75.08 | 1115 / 1118 |
liver | 100% | 2965.19 | 225 / 226 | 100% | 40.67 | 406 / 406 |
pancreas | 98% | 2215.36 | 322 / 328 | 99% | 52.65 | 177 / 178 |
adrenal gland | 100% | 3286.70 | 258 / 258 | 94% | 36.27 | 217 / 230 |
adipose | 100% | 4846.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4489.82 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 63.24 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 121.90 | 29 / 29 |
peripheral blood | 100% | 11233.31 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 8194.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 54.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 51.52 | 1 / 1 |
muscle | 100% | 3529.46 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 4326.75 | 856 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006913 | Biological process | nucleocytoplasmic transport |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0042393 | Molecular function | histone binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | ANP32A |
Protein name | Acidic leucine-rich nuclear phosphoprotein 32 family member Acidic leucine-rich nuclear phosphoprotein 32 family member A (Acidic nuclear phosphoprotein pp32) (pp32) (Leucine-rich acidic nuclear protein) (LANP) (Mapmodulin) (Potent heat-stable protein phosphatase 2A inhibitor I1PP2A) (Putative HLA-DR-associated protein I) (PHAPI) |
Synonyms | LANP PHAP1 MAPM C15orf1 |
Description | FUNCTION: Multifunctional protein that is involved in the regulation of many processes including tumor suppression, apoptosis, cell cycle progression or transcription . Promotes apoptosis by favouring the activation of caspase-9/CASP9 and allowing apoptosome formation . In addition, plays a role in the modulation of histone acetylation and transcription as part of the INHAT (inhibitor of histone acetyltransferases) complex. Inhibits the histone-acetyltranferase activity of EP300/CREBBP (CREB-binding protein) and EP300/CREBBP-associated factor by histone masking . Preferentially binds to unmodified histone H3 and sterically inhibiting its acetylation and phosphorylation leading to cell growth inhibition . Participates in other biochemical processes such as regulation of mRNA nuclear-to-cytoplasmic translocation and stability by its association with ELAVL1 (Hu-antigen R) . Plays a role in E4F1-mediated transcriptional repression as well as inhibition of protein phosphatase 2A . .; FUNCTION: (Microbial infection) Plays an essential role in influenza A, B and C viral genome replication . Mechanistically, mediates the assembly of the viral replicase asymmetric dimers composed of PB1, PB2 and PA via its N-terminal region . Also plays an essential role in foamy virus mRNA export from the nucleus . . FUNCTION: Multifunctional protein that is involved in the regulation of many processes. . FUNCTION: Multifunctional protein that is involved in the regulation of many processes. . FUNCTION: Multifunctional protein that is involved in the regulation of many processes. . FUNCTION: Multifunctional protein that is involved in the regulation of many processes. . FUNCTION: Multifunctional protein that is involved in the regulation of many processes. . |
Accessions | ENST00000560303.1 ENST00000409628.6 Q6PKH8 H0YN26 Q08AJ6 Q3KPI8 P39687 ENST00000465139.6 H7BZ09 |